Skip to main content

General Psychiatry

October 05, 2019
SAN DIEGO—Psilocybin-assisted psychotherapy is showing promise in research examining effects on depressive symptoms and substance use, but no trials have reached phase 3 and eventual approval of the treatment remains uncertain, a researcher reported at Psych Congress 2019.
October 05, 2019
SAN DIEGO—Cannabidiol (CBD) has quickly entered the mainstream, but there is a dearth of evidence about the effects of the cannabis byproduct, a speaker told a large audience at Psych Congress 2019.
October 04, 2019
SAN DIEGO—Psychiatrists need more knowledge of genetics because patients are coming to them armed with questions, and often their own genetic test results. But provider training has lagged, and the use of genetic data to inform treatment remains a work in progress, Indiana University Professor of…
October 03, 2019
SAN DIEGO—Data has the power to give mental health clinicians a better understanding of patients and their well-being, and today’s technology can easily collect and disseminate that data, physician and entrepreneur Arshya Vahabzadeh, MD, told attendees at the opening session of Psych Congress 2019.
October 03, 2019
SAN DIEGO—Charles F. Zorumski, MD, presented an update on gamma-aminobutyric acid (GABA), a complex neurotransmitter he has been studying for more 30 years, at the Psych Congress 2019 Practical Psychopharmacology Pre-Conference.
October 01, 2019
HMP today announced it has entered into a partnership agreement with the Milton H. Erickson Foundation for the Evolution of Psychotherapy Conference, the world’s largest independent educational event for mental health professionals.
September 27, 2019
People who work night shifts or varied schedules that disrupt their sleep may be more likely to develop depression than individuals with 9-to-5 jobs, a research review suggests.
September 27, 2019
Get a behind-the-scenes look at some of the sessions taking place at the 32nd annual Psych Congress, and meet the experts presenting them.
September 23, 2019
Phillip Resnick, MD, a psychiatry professor at Case Western Reserve University, Cleveland, Ohio, will brief mental health providers on how to recognize potential school shooters in their own practices at Psych Congress 2019.
September 18, 2019
The majority of studies included in a new literature review identified significant improvement in a variety of psychiatric disorders among patients who took hallucinogenic drugs.
Back to Top